Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CHKA | P35790 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | NCF1 | P14598 | 1/20 | 0.40 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL316062 | 0.98 | ALDH1A1 (0.46) | KDM4EALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL19020394 | 0.95 | ALDH1A1 (0.48) | KDM4EALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL8860543 | 0.89 | ALDH1A1 (0.56) | KDM4EALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL12958917 | 0.89 | ALDH1A1 (0.56) | KDM4EALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL27220451 | 0.89 | ALDH1A1 (0.56) | KDM4EALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL17085988 | 0.87 | ALDH1A1 (0.54) | KDM4EALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL8753 | 0.87 | ALDH1A1 (0.54) | KDM4EALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL17085900 | 0.87 | ALDH1A1 (0.54) | KDM4EALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL378213 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL7893275 | 0.84 | ALDH1A1 (0.52) | KDM4EALDH1A1KMT2AMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2691443-B1 | CONJUGATED LIPOMERS AND USES THEREOF | MASSACHUSETTS INST TECHNOLOGY (US) | 2021-02-17 | — | — | EP | disclosed |
| US-20190167795-A1 | CONJUGATED LIPOMERS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190167795-A1 | CONJUGATED LIPOMERS AND USES THEREOF | EZH2, LIPC, PUF60 | KDM4E 812/4885ALDH1A1 1831/4885KMT2A 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.